SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 136 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $589,000 | +49.9% | 39,300 | +17.0% | 0.00% | 0.0% |
Q1 2016 | $393,000 | -7.1% | 33,600 | +26.3% | 0.00% | 0.0% |
Q4 2015 | $423,000 | +3.7% | 26,600 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $408,000 | -26.1% | 26,600 | +17.2% | 0.00% | 0.0% |
Q2 2015 | $552,000 | +16.5% | 22,700 | +11.3% | 0.00% | 0.0% |
Q1 2015 | $474,000 | -7.4% | 20,400 | 0.0% | 0.00% | -50.0% |
Q4 2014 | $512,000 | -19.2% | 20,400 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $634,000 | +20.1% | 20,400 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $528,000 | +55.8% | 20,400 | +40.7% | 0.00% | +100.0% |
Q1 2014 | $339,000 | +15.3% | 14,500 | +25.0% | 0.00% | 0.0% |
Q4 2013 | $294,000 | +24.1% | 11,600 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $237,000 | +13.9% | 11,600 | +17.2% | 0.00% | 0.0% |
Q2 2013 | $208,000 | – | 9,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 462,824 | $7,364,000 | 8.63% |
HealthCor Management, L.P. | 1,750,000 | $27,843,000 | 1.69% |
ACUTA CAPITAL PARTNERS, LLC | 144,667 | $2,302,000 | 1.10% |
THB ASSET MANAGEMENT | 615,546 | $9,793,000 | 1.05% |
Penn Capital Management Company, LLC | 1,399,205 | $22,261,000 | 0.98% |
Tamarack Advisers, LP | 450,000 | $7,160,000 | 0.94% |
Piermont Capital Management Inc. | 139,020 | $2,212,000 | 0.70% |
JW Asset Management, LLC | 101,630 | $1,617,000 | 0.60% |
SECTORAL ASSET MANAGEMENT INC | 810,362 | $12,893,000 | 0.55% |
Glacier Peak Capital LLC | 50,000 | $796,000 | 0.51% |